COMMUNIQUÉS West-GlobeNewswire

-
HealthEquity Reports First Quarter Ended April 30, 2019 Financial Results
04/06/2019 -
TG Therapeutics Presents Positive Interim Data from UNITY-NHL Phase 2b Trial Evaluating Umbralisib Monotherapy in Patients with Marginal Zone Lymphoma at the 55th American Society of Clinical Oncology (ASCO) Annual Meeting
04/06/2019 -
Aptose Biosciences Announces Results of Annual and Special Meeting of Shareholders
04/06/2019 -
Affimed Announces Annual General Meeting of Shareholders
04/06/2019 -
Nabriva Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/06/2019 -
Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock
04/06/2019 -
XBiotech Announces Closing of Public Offering of Common Shares
04/06/2019 -
AB Science is providing a summary of the web conference held on 4 June 2019
04/06/2019 -
AB Science fournit un résumé de la conférence web qui s’est tenue le 4 juin 2019
04/06/2019 -
Axiom Real-Time Metrics Showcasing Fusion eClinical Suite at BIO International Convention in Philadelphia
04/06/2019 -
Long-term survival benefit shown for metastatic melanoma patients treated with Novartis Tafinlar® + Mekinist®
04/06/2019 -
Pathway Health Announces Distribution Agreement with MED-PASS
04/06/2019 -
Virbac : Declaration of the number of shares and voting rights May 2019
04/06/2019 -
Virbac : Déclaration d'actions et de droits de vote mai 2019
04/06/2019 -
Novitium Pharma Launches Generic Revatio® for Oral Suspension, 10mg/mL
04/06/2019 -
Taconic Biosciences est le premier et le seul vendeur d'animaux à annoncer que toutes ses colonies de souris de laboratoire sont exemptes du nouvel agent pathogène
04/06/2019 -
Pivotal phase III CLL14 results for Venclexta/Venclyxto in combination with Gazyva/Gazyvaro for chronic lymphocytic leukaemia presented at ASCO 2019 and published in the New England Journal of Medicine
04/06/2019 -
Avricore Health Announces Lifting of Management Cease Trade Order
04/06/2019 -
Repligen to Present at Jefferies 2019 Healthcare Conference
04/06/2019
Pages